EP 1337250 A2 20030827 - USE OF P38 INHIBITORS FOR THE TREATMENT OF SMOKE INHALATION
Title (en)
USE OF P38 INHIBITORS FOR THE TREATMENT OF SMOKE INHALATION
Title (de)
VERWENDUNG VON P38-HEMMERN ZUR BEHANDLUNG VON RAUCHINHALATION
Title (fr)
UTILISATION D'INHIBITEURS DE P38 POUR LE TRAITEMENT DE TROUBLES DUS A L'INHALATION DU TABAC
Publication
Application
Priority
- US 0150429 W 20011019
- US 24156800 P 20001019
Abstract (en)
[origin: WO0232862A2] The present invention is directed to the novel use of a CSBP/p38 inhibitor for the treatment, including prophylaxis of smoke induced pathology resulting from acute and chronic inflammation in the lung.
[origin: WO0232862A2] The present invention is directed to the novel use of a CSBP/p38 inhibitor for the treatment, including prophylaxis of smoke induced pathology resulting from acute and chronic inflammation in the lung.
IPC 1-7
IPC 8 full level
A61K 45/00 (2006.01); A61K 31/00 (2006.01); A61K 31/4439 (2006.01); A61K 31/513 (2006.01); A61K 45/06 (2006.01); A61P 11/00 (2006.01); A61P 11/02 (2006.01); A61P 11/06 (2006.01); A61P 27/16 (2006.01)
CPC (source: EP)
A61K 31/00 (2013.01); A61K 31/4439 (2013.01); A61K 45/06 (2013.01); A61P 11/00 (2017.12); A61P 11/02 (2017.12); A61P 11/06 (2017.12); A61P 27/16 (2017.12)
Citation (search report)
See references of WO 0232862A2
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
DOCDB simple family (publication)
WO 0232862 A2 20020425; WO 0232862 A3 20020822; AU 3128302 A 20020429; EP 1337250 A2 20030827; JP 2004511542 A 20040415
DOCDB simple family (application)
US 0150429 W 20011019; AU 3128302 A 20011019; EP 01987743 A 20011019; JP 2002536046 A 20011019